Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2023-03-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnetic Resonance Imaging in Cerebral Small Vessel Disease
NCT05200377
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Analysis for Prognosis of Intracranial Dissecting Aneurysm With Intramural Hematoma After Endovascular Treatment
NCT03940859
Imaging the Pathogenesis of Cerebral Small Vessel Disease
NCT05703386
ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS
NCT05458908
Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome
NCT02756416
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CVOD-WS
Cerebral Venous Outflow Disturbance with symptoms such as tinnitus cerebri,somnipathy ,anxiety ,depression and cognitive decline
high-resolution 3D-T1
Subjects undergo a high-resolution 3D-T1 imaging to obtain structural images
diffusion tensor imaging (DTI)
Subjects undergo a DTI imaging to obtain images of white matter lesions
resting-state functional magnetic resonance imaging (rs-fMRI)
Subjects undergo rs-fMRI to investigate the differences in intra-regional brain activity and inter-regional functional connectivity
arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI)
Subjects undergo arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) to clarify the difference of cerebral blood flow (CBF) perfusion in certain regions
susceptibility-weighted images (SWIs)
Subjects undergo susceptibility-weighted images (SWIs) to segment the vein network
CVOD-WOS
Cerebral Venous Outflow Disturbance without symptoms such as tinnitus cerebri,somnipathy ,anxiety ,depression and cognitive decline
high-resolution 3D-T1
Subjects undergo a high-resolution 3D-T1 imaging to obtain structural images
diffusion tensor imaging (DTI)
Subjects undergo a DTI imaging to obtain images of white matter lesions
resting-state functional magnetic resonance imaging (rs-fMRI)
Subjects undergo rs-fMRI to investigate the differences in intra-regional brain activity and inter-regional functional connectivity
arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI)
Subjects undergo arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) to clarify the difference of cerebral blood flow (CBF) perfusion in certain regions
susceptibility-weighted images (SWIs)
Subjects undergo susceptibility-weighted images (SWIs) to segment the vein network
HC
Healthy control
high-resolution 3D-T1
Subjects undergo a high-resolution 3D-T1 imaging to obtain structural images
diffusion tensor imaging (DTI)
Subjects undergo a DTI imaging to obtain images of white matter lesions
resting-state functional magnetic resonance imaging (rs-fMRI)
Subjects undergo rs-fMRI to investigate the differences in intra-regional brain activity and inter-regional functional connectivity
arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI)
Subjects undergo arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) to clarify the difference of cerebral blood flow (CBF) perfusion in certain regions
susceptibility-weighted images (SWIs)
Subjects undergo susceptibility-weighted images (SWIs) to segment the vein network
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
high-resolution 3D-T1
Subjects undergo a high-resolution 3D-T1 imaging to obtain structural images
diffusion tensor imaging (DTI)
Subjects undergo a DTI imaging to obtain images of white matter lesions
resting-state functional magnetic resonance imaging (rs-fMRI)
Subjects undergo rs-fMRI to investigate the differences in intra-regional brain activity and inter-regional functional connectivity
arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI)
Subjects undergo arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) to clarify the difference of cerebral blood flow (CBF) perfusion in certain regions
susceptibility-weighted images (SWIs)
Subjects undergo susceptibility-weighted images (SWIs) to segment the vein network
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Accompanying symptoms such as tinnitus cerebri, cognitive decline, anxiety depression, sleep disorders, etc. for more than 6 months
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ji Xunming,MD,PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xunming Ji, MD.PhD
Role: PRINCIPAL_INVESTIGATOR
Xuanwu Hospital, Beijing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xuanwu hospital;Capital Medical University
Beijin, XI Cheng District, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Luan Y, Wang C, Jiao Y, Tang T, Zhang J, Teng GJ. Prefrontal-Temporal Pathway Mediates the Cross-Modal and Cognitive Reorganization in Sensorineural Hearing Loss With or Without Tinnitus: A Multimodal MRI Study. Front Neurosci. 2019 Mar 12;13:222. doi: 10.3389/fnins.2019.00222. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVD-BI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.